Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation

7680668080021 CH-66808 Einzeldosiertes Pulver zur Inhalation
Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation
Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation
Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation
1 / 3
google

Article details

Package size
3 x 30
Selling units
90
Measure
Einzeldose(n)
Galenic form
Einzeldosiertes Pulver zur Inhalation
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/06/2025
Patient information leaflet
Français
30/06/2025
Patient information leaflet
Italien
30/06/2025
Summary of Product Characteristics
Allemand
30/06/2025
Summary of Product Characteristics
Français
30/06/2025
Summary of Product Characteristics
Italien
30/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
92.0 UG Substance Wirkstoff (Principe actif)
(N/A)
55.0 UG Substance Wirkstoff (Principe actif)
(N/A)
65.3 UG Substance WIZUS
(N/A)
22.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 228.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2019

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
66808
Drug name
Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation
Galenic form
PULIN
ATC Code
R03AL08
Authorization status
Z
Dispensing category
B
First authorization
20/09/2018
Authorization expiration date
31/12/9999
IT Number
03.99.0.
Domain
Human medicine
Field of application
COPD

Package details

Description (FR)
TRELEGY ELLIPTA pdr inh 92/55/22mcg 3 x 30 dos
Description (DE)
TRELEGY ELLIPTA Inh Plv 92/55/22mcg 3 x 30 Dos
Market launch
20/09/2018
Narcotic (BTM)
No

Other package sizes (1)

TRELEGY ELLIPTA pdr inh 92/55/22mcg 30 dos
30 EINZ
GTIN: 7680668080014
View